Welcome to the Golub Capital BDC, Inc. March 31, 2020 Quarterly Earnings Conference Call. Before we begin, I would like to take a moment to remind our listeners that remarks made during this call may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts made during this call may constitute forward-looking statements and are not guarantees for future performance or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in Golub Capital BDC, Inc.'s filings with the Securities and Exchange Commission. For materials, the company intends to refer to on today's earnings conference call, please visit the Investor Resources tab on the homepage of the company's website www.golubcapitalbdc.com and click on the Events/Presentations link. Golub Capital BDC's earnings release is also available on the company's website in the Investor Resources section. As a reminder, this call is being recorded for replay purposes. I will now turn the call over to David Golub, Chief Executive Officer of Golub Capital BDC.

Thanks, Selena. Hello everyone and thanks for joining us today. I am joined virtually today by Ross Teune, our Chief Financial Officer, Gregory Robbins and Jon Simmons, both Managing Directors at Golub Capital. We and the rest of the Golub Capital team hope that you and your loved ones are all safe in these challenging times. We are grateful that our team is healthy, safe and working effectively from home. We're going to talk a lot today about the economic impacts of COVID-19 but first I want to take a moment to acknowledge the human impact. About half of Golub Capital's team- myself included - lives in or near New York City and I'm sure everyone on this call has read about how New York city has been hard hit by COVID with over 170,000 documented cases and over 140,000, I'm sorry over 14,000 confirmed deaths. The impact of COVID-19 in our community is palpable, we all know folks who've been sick or worse. What's also palpable is a spirit of resilience and solidarity. In my neighborhood and across the city, we open our windows at 7 PM every night to clap and cheer for the healthcare workers who are on the front lines. We've been doing it for weeks and it's still a very emotional moment for me and, I think, for most people. The New York Times recently featured an opt-ed by my friend Nick Kristof that highlighted a number of exceptional organizations that are involved in COVID-19 relief. We're proud to support their work and I hope you'll consider joining us. This morning we issued our earnings press release for the quarter ended March 31, 2020 and we posted an earnings presentation on our website. We'll refer to that presentation through the call today. Let me start…

Thank you David. Turning to Slide 16, we have been focusing on two key strategies. First, proactively managing our portfolio and second fortifying GBDC's balance sheet. Let's discuss each in turn. The first focus area on Slide 17 has been proactive portfolio management. There have been three phases to this. In the first phase, which began earlier this year, we opened up lines for communication with our portfolio companies, private equity sponsors and industry consultants to gather data and assess COVID-19 risk by borrower. In support of these efforts, the Golub Capital direct lending team consisting of more than 130 professionals pivoted from loan origination to portfolio management. We undertook detailed analysis using 13-week cash flow forecasts, real time sales figures and other proprietary data to segment the portfolio and identify the most affected borrowers. In the second phase, we developed and executed on short term game plans for the borrowers most affected by COVID-19. We also helped many of our borrowers apply for loans under government programs where this was appropriate. In the third phase, which is where we are now, we are designing and executing on longer-term game plans for all of our borrowers. We are doing this collaboratively with the management teams and sponsors of each company. In the many cases where the borrowers are doing fine despite COVID-19, the game plan is business as usual. In more challenging cases, we are focused on credit-enhancing amendments or on incremental investments where we, as first lien lenders may contribute to a solution alongside capital support from the private equity sponsors. Every deal is different but we think our deep partnerships with sponsors and our lead position on the preponderance of our loans has given us the power and the nimbleness to structure win-win solutions. Where sponsors are unable…

Thanks Gregory. I'm on Slide 22. First, just as a reminder, in addition to the GAAP financial measures in our investor presentation we've also provided certain non-GAAP measures to make GBDC's financial results easier to compare to our results prior to our merger with GCIC. These non-GAAP or “adjusted” measures seek to strip out the impact of the merger-related purchase premium write-off and amortization and are further described in the appendix of our earnings presentation. We'll refer to these adjusted measures where appropriate as we think they are a better indicator of GBDC's financial performance. With that context, let's look at the results for the quarter in the column on the far right of the page. Adjusted net investment income per share or, as we call it, income before credit losses for the March 31,2020 quarter was $0.33, unchanged from the previous quarter. Adjusted net realized and unrealized loss per share was $2.04. This compares to adjusted net realized and unrealized gain per share of $0.02 for the quarter ended December 31, 2019. As David discussed in his remarks, the adjusted net realized and unrealized loss for this quarter was primarily driven by unrealized losses from the impact of COVID-19. Loss per share and adjusted loss per share for the March 31,2020 quarter was $1.71, this compares to earnings per share and adjusted earnings per share to the December 31, 2019 quarter of $0.35. As a result of a loss per share, our NAV per share declined approximately 12.2% to $14.62 as of March 31 from $16.66 at December 31. On March 30, 2020 we paid a quarterly distribution of $0.33 per share and then finally on April 9, 2020 our board declared a quarterly distribution of $0.29 per share payable on June 29, 2020 to stockholders of record as of June 9, 2020. This distribution is consistent with historical quarterly cash distributions and an annualized rate of approximately 8% of net asset value. I'll now hand the call over to Ross to go through the results in more detail. Ross.

Great, thanks Jon. I'll start on Slide 23. This slide highlights our total originations of $167 million and total exits and sales of investments of $291 million for the quarter ended March 31, 2020 factoring an unrealized depreciation and other portfolio activity including a record level of revolver fundings, total investments at fair value decreased by 5.4% or approximately $238.1 million. One point I want to highlight, as of March 31, 2020 we had just $17.5 million of remaining undrawn commitments on revolvers and $134.1 million of remaining undrawn commitments on delayed draw term loans. These are small numbers in the context that GBDC's balance sheet and liquidity position. As shown on the bottom table, the weighted average rate of 7.1% on new investments, the weighted average spread over LIBOR on new floating rate investments of 5.2% and the weighted average fee on new investments all declined from the prior quarter primarily due to a higher percentage of traditional senior secured originations this quarter. The weighted average rate on investments that paid off of 7.7% was relatively consistent with the prior quarter. As a reminder the weighted average interest rate and new investments is based on the contractual interest rate at the time of funding. For variable rate loans, the contractual rate would be calculated using current LIBOR, the spread over LIBOR and the impact of any LIBOR floor. The top of Slide 24 shows that GBDC's portfolio remained highly diversified by obligor with an average investment size of less than 40 basis points. The bottom of the slide shows that our overall portfolio mix by investment type has remained consistent quarter-over-quarter with one-stop loans continuing to represent our largest category at 82%. Turning to Slide 25, 97% of our investment portfolio remains in first lien, senior secured floating rate…

Thanks Ross. So to summarize today's discussion, the COVID-19 outbreak led to credit stress and wider spreads in calendar Q1 2020. This in turn caused large unrealized losses in GBDC's portfolio. Our key priority now is to proactively manage the portfolio to minimize realized credit losses. If we are successful, the rest will take care of itself. At GBDC we have a long and industry-leading track record of keeping credit losses low including from many prior periods of market uncertainty and volatility. We believe we enter this period with a series of compelling competitive advantages that are stronger than ever including our experienced team, scale, sponsor relationships and industry expertise. Our track record, our competitive advantages and the deep sense of humility should position us well to manage GBDC through these challenging times. With that let me thank you for your time today and for your partnership. Operator please open the line for questions.

Thank you. [Operator Instructions] Our first question comes from the line of Finian O'Shea of Wells Fargo. Please go ahead with your question.

Hi, good morning -- good afternoon. Thanks for having me on and everyone's doing well. David first question on the rights offering proceeds. I think Greg actually gave a bit of a breakdown there. Are you able to provide any more color on the split between debt pay down and new commitments? And on new credit enhancing commitments, what kind of pipeline do you have now for those portfolio opportunities?

Great. So let me address each of those two questions. So let's talk first about rights offering proceeds. I don't have an exact answer for you right now but I can give you a directional answer. Let's start with the goals that we're undertaking to apply the rights offering proceeds to pursue. We want to use the proceeds to fortify liquidity and to create more flexibility. So that combination will equip us to play both offense and defense within the portfolio and capitalize on what Gregory was talking about the attractive lending environment that we're anticipating is going to develop once the M&A market regains its footing. So we're currently thinking is that we'll use about $140 million of the proceeds to retire several older debt facilities that are no longer in their reinvestment periods. There's the 2014 CLO that's been winding down and there's the two SLF facilities. By paying off those facilities we create a large amount of unencumbered assets to add to what is already a large amount of unencumbered assets on GBDC's balance sheet. We're also in discussions to expand one or more of our long-term bank facilities. In combination, the increase in unencumbered assets and the increase in size of one or more of our long-term bank facilities should put us in a position where we have ample liquidity, we have significant availability under our debt facilities and we have hundreds of millions in unencumbered assets. So I'm pleased with how that's developing. We also plan to continue to explore other debt alternatives including unsecured notes when the market becomes more attractive for this. Second question you asked and if I understood it right was, what's the pipeline look like for these credit enhancing incremental investments that you've heard me talk about and the answer is it's good. We're in a lot of discussions right now with sponsors as you would imagine to address longer-term amendments and in many cases those amendments will include some combination of new investment by sponsors, deferral of interest by junior debt providers, some improvement in our credit position, in some cases a re-pricing of our loans, in some cases a new investment by us on attractive terms. So we've got a large number of those that we're working on right now and I think that sort of transaction is going to be the focus of what we're working on over the course of the next three or four months. And we're going to continue to look at the potential to do new deals but the truth is there's not much new going on right now. As Gregory put it, the M&A market is dead because buyers and sellers can't agree on the day of the week. So it's both timely for us to be focused on these credit enhancing incrementals in our own portfolio and there's also not much competition for time in respect of that.

Thank you. That was very good color. I was more or less answered or sort of my next question on the Morgan Stanley credit facility amendment. We know that was the relapse --collapsed in commitment was pushed out just one quarter presumably there would need to be cash proceeds to pay that down. You just kind of touched on that. You're looking at other forms of unsecured and other debt there but anything we should look at given the sort of near-term from here reduction in that credit capacity?

So I think what you're alluding to is that in our filings last quarter we indicated that we extended, but not permanently, a portion of the Morgan Stanley bank facility. We are in discussions with Morgan Stanley and with our other bank providers about the right mix of commitments under our long-term bank facilities. The truth is we don't need all of that Morgan Stanley facility. So maintaining it in its current form is not something that that we would like to pursue but we've got a number of different options that are attractive. We're going to make a final decision on that in the coming weeks.

Okay. Thank you. And just one final for me. I will hop back in. On the dividend, recently reduced to $0.29 as part of the portfolio update, is the BDC able to earn that payout through the rights offering transaction? A - David Golub I think there are a lot of factors right now that are going to impact NAV per share. We just went through a quarter where we had a very significant unrealized loss that reduced NAV per share. When I think about dividends for GBDC, what I would like to see us have is a steady dividend that slowly increases over time and that's what we did for about 10 years prior to the COVID-19 quarter. So we've got to assess prospectively is -- where is NAV per share going to settle post the uncertainties associated with COVID-19. I think once we have more clarity about that we will be able to have a firmer answer on your question. I think right now the answer to your question is we're just going to, along with everybody else, have to muddle through with the uncertainties created by this COVID-19 environment.

Okay. It's all for me. Thanks so much.

Thank you. Our next question comes from the line of Ryan Lynch of KBW. Please go ahead with your question.

Hey, good afternoon. First I wanted to just touch again on the rights offering. I know you guys gave some general commentary on kind of the thoughts behind why that was done but was one of the primary reasons behind the rights offering, you did have to do with any concerns of potential covenant breaches surrounding any of your securitizations and the potential impact of diverting cash flows to pay down those securitizations versus cash flows that were required to be paid out the dividend regarding RIC status?

No. I don't think it was quite as you described it. I would describe it somewhat differently. I would say that COVID-19 created an environment in which we saw a much wider range of potential future scenarios than we typically do. So if you typically think about the future in terms of a bell curve and you shape your base case assumptions around the middle of the bell curve you can create an upside case and a downside case that are a little off of that base case and cover the vast preponderance of potential scenarios. In a COVID-19 world you can't do that. The curve is a very different shape. It's much flatter with much flatter tails. So as an asset manager in a COVID-19 world, we came to the conclusion that it made sense to have more flexibility in our capital structure to be able to manage effectively through a much wider array of different scenarios. Now in some of those scenarios we were concerned that we wouldn't have sufficient capital to be able to do these credit enhancing incremental investments and simultaneously to be able to make best use of the low cost liabilities that GBDC contractually has. So I'm not saying Ryan that your question isn't the right question. I think that -- those concerns are among a whole slew of concerns that drove us to conclude that the rights offering was the right thing to do. I put that larger group of concerns under the rubric of an increased level of uncertainty in the environment and a desire to have a balance sheet that would work well in the context of a wider array of different forward scenarios. I feel very good about where we are now.

Okay. I mean, do you think that longer term, this will have you revaluate how you compose the right side of your balance sheet given that you guys ran with zero unsecured notes or unsecured debt which a lot of other BDCs have chosen to make that part of their liability structure which is obviously the higher cost debt, which is bad during the up times but in down time like this it creates a significant amount of unencumbered assets to become very important the downturn like this and I don't know if we're going to see BDCs do dilutive rights offerings like this, especially the ones with significant amounts of unsecured debt. So do you think that you will rethink your liability structure going forward as far as the composition of it goes?

We had already rethought our liability structure and as I commented on in the September quarter discussion and in the December quarter discussion, we had begun a serious evaluation of getting investment-grade rating and issuing unsecured notes. So I'm a believer in unsecured notes, I think that we have a place in the liability structure of a scaled BDC and I'm sure it's something we're going to be seeking to explore subject to that market normalizing in terms of costs.

Okay. And then just kind of a technical one. With unfunded commitments I think you guys had a $152 million at the end of the quarter. What was the level of unfunded commitments that were revolvers or commitment that were kind of at a full discretion of the borrower to drawdown versus commitments that has some sort of like delayed draw term loan? Or were not at the full discretion of the borrower to draw down?

The vast preponderance of our ongoing commitments at quarter end were in the form of acquisition focused DDTLs, I think we were down to $16 million of revolvers that were undrawn. Most obligors drew their revolvers in March of 2020.

Okay. And then --.

We did break that down in our 10Q this quarter. Ryan. So its $17.5 million was the exact number of unfunded revolvers.

Thank you, Ross. Thank you, [at least we had] okay. And then one other one. As far as calendar second quarter, so the June quarter ended, assuming that there's no change in fair value for your portfolio, it's just how confident. Do you anticipate the total return look back each of your incentive fee structure kicking in holding everything else equal? I'm just trying to get a feel for what you guys are looking at versus my model.

Let us review that with you offline, I think we still have some cushion before the NII incentive fee, look back would restrict NII incentives but also tell you that we don’t anticipate that NII incentive fees are going to be terribly high in the near term.

Okay. Yes, okay. Thanks for taking my questions, I appreciate the time. I'll hop back in the queue.

Thank you. Our next question comes from the line of Matt Tjaden of Raymond James. Please go ahead with your question.

Hi everyone, afternoon and hope all is well. So just two quick ones. The first one revolving around sponsor attitude and willingness to put in more capital. So just any general commentary you can give there and specifically, I guess what we would be interested in, is whether or not there is any difference in willingness to put in more capital by industry. So, for example, for our retail portfolio company versus more of a staple say healthcare. Is there any difference in willingness to put in more capital? Thank you.

I would say there's not a difference based on industry. What matters most in discussions with sponsors about level of sponsor support are two factors. The first factor is to what degree they like the company see the capacity for its performance to rebound and for it to be a successful investment for them. Sponsors for obvious reasons, the economic animals they want to focus their resources on those companies that are going to do well for them. The second issue which comes up sometimes and infrequently but sometimes, it's that a particular investment comes from an older fund and the sponsor has limited resources remaining that are available to it in that older fund. And it may have some competing needs in the context of COVID-19. So where we anticipate some of the most challenging conversations with sponsors are, are those that are in the second category where the sponsor would like to provide support but doesn’t have the capacity to do so to the degree would like to. I would say on balance -- and look it's still early days, but on balance we've been very gratified by the way in which sponsors have engaged with us in a very solutions oriented collaborative fashion.

Great, that's helpful. And then last one, just any color you can provide on the scale of amendment reliefs within the quarter and then through April whether or not that has sped up would be very helpful. Thank you.

We had relatively little in terms of amendment activity in calendar Q1. There were roughly a dozen companies that were heavily impacted by COVID-19 where we agreed to reduce the cash piece spread of our loans and to have a portion of the spread be payable in PIK. Virtually all or I think all but one of our borrowers repaid their principle and interest in the quarter. I anticipate there will be a need for a lot of amendments going forward. I think most of those amendments are going to be in calendar Q3 actually as opposed to calendar Q2. Bear in mind that for most companies they had two good months and one bad month in Q1. So Q1 financial results will -- in the preponderance of cases not trip covenants. Q2 financial performance, however is going to be harder for many companies not to trip covenants. So those financial statements would be due over the summer and that would be when I would anticipate the biggest crunch of amendments would be needed.

That's all from me. Thanks guys, I appreciate it.

Thank you. [Operator Instructions.]

And Selena, let’s do one more.

And at this present time no one has registered for any questions. Please continue with your presentation or closing remarks. End of Q&A:

Excellent. I just want to thank everyone. This was a long call, I know, we wanted to provide a lot of data to help everyone understand the COVID-19 consequences and challenges perceptively. Hope this was helpful. Thank you for listening. Thank you for your partnership. And as always, please feel free to reach out to us if you have further questions. Look forward to chatting next quarter.

Thank you. That does conclude the conference call for today. We thank you for your participation and ask that you please disconnect your lines.